Gaganyaan Enters Final Phase: India’s First Human Spaceflight Targeted for 2027

India is preparing to script history with its first human spaceflight under the Gaganyaan programme, which has now entered its final and most critical phase. The mission aims to send Indian astronauts into low Earth orbit by the first quarter of 2027 — a defining milestone in the country’s journey as a space-faring nation.
At a media interaction held at the National Media Centre, Union Minister Dr Jitendra Singh, who oversees the Department of Space, provided key insights into the mission’s status and broader national impact. ISRO Chairman Dr V. Narayanan was also present to address technical progress.
Key Tests Completed, Crewed Launch on the Horizon
The successful execution of the Test Vehicle Abort Mission (TV-D1) earlier this year laid a solid foundation for the next steps. The second test mission (TV-D2) is scheduled for later in 2025, followed by two uncrewed orbital flights. These crucial milestones will lead up to India’s first human spaceflight, to be launched aboard the Gaganyaan module atop an Indian-built rocket from Indian soil.
Read More: India’s Space Tech Boom: Top Spacetech Shares in India 2025.
Building India’s Indigenous Spaceflight Infrastructure
The mission involves the development of a human-rated launch vehicle (LVM3), a Crew Escape System, and a Crew Module with associated Service Module — all of which are undergoing final testing and integration. Dr Singh reiterated that Gaganyaan exemplifies India’s ability to execute complex missions with a focus on cost-effectiveness and home-grown technology.
Training Indian Astronauts: Ready for Orbit
The four Indian Air Force pilots selected as astronaut-designates have completed their basic training in Russia and are now undergoing advanced mission-specific preparation in India. Their health, operational readiness, and psychological fitness are being continuously monitored. Meanwhile, successful recovery trials have been conducted in collaboration with the Indian Navy, with further simulations planned.
Gaganyaan: More Than a Mission, A National Movement
Dr Singh described Gaganyaan as a “historic mission” that symbolises more than technological success. It reflects India’s emergence as a global space leader built on indigenous capabilities and visionary governance. The programme is expected to stimulate economic growth, technological innovation, and national pride.
He further highlighted India’s long-term space ambitions, including establishing the Bharatiya Antariksha Station by 2035 and sending the first Indian to the Moon by 2040 objectives that were clearly laid out by Prime Minister Narendra Modi.
Economic and Technological Spinoffs Already Visible
The Gaganyaan initiative is already bearing fruit in the form of technological spinoffs across robotics, materials science, electronics, and medical technologies. It has also catalysed collaboration with private enterprises and startups, signalling a vibrant and inclusive space economy.
Conclusion
ISRO’s leadership reiterated that Gaganyaan is no longer just a space agency mission — it is India’s mission. As the nation edges closer to its first human spaceflight, the programme stands as a beacon of strategic ambition, scientific excellence, and collaborative progress.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Published on: May 7, 2025, 2:46 PM IST

Team Angel One
- ArMee Infotech Limited IPO Allotment Status
- TRAI Mandates Enhanced Voice and SMS Only Recharge Plans
- Air India Plans to Launch New In-Flight Entertainment Platform in 2027
- SEBI Expands AI Use to Monitor Market Manipulation and Online Fraud
- Stocks to Watch Today: Lumino Industries, Augmont Enterprises, Symbiotec Pharmalab and Others (September 22, 2026)


